Ambu A/S (AMBBY) Stock Price, News & Analysis

Company Overview

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics. Its endoscopy offerings are used in pulmonary, gastrointestinal and other clinical applications, while its anesthesia and airway products support the care of patients before, during and after medical procedures.

Founded in 1937 by Holger Hesse, Ambu is headquartered in Ballerup, Denmark, and serves healthcare markets internationally, including Europe, North America and the Asia-Pacific region. The company is led by Chief Executive Officer Britt Meelby Jensen, who has served in that role since 2023.

Key Stats

• Today's Range: $10.23 to $10.23
• 50-Day Range: $10.20 to $11.65
• 52-Week Range: $8.55 to $16.78
• Volume: 1,000 shs
• Average Volume: 88 shs
• Market Capitalization: $2.40 billion
• P/E Ratio: 34.08
• Dividend Yield: 0.29%
• Price Target: N/A
• Consensus Rating: Hold

Ambu A/S Stock Analysis - MarketRank™

Ambu A/S scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Ambu A/S has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Ambu A/S has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ambu A/S is 34.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ambu A/S is 34.08, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.82.

Price to Book Value per Share Ratio

Ambu A/S has a P/B Ratio of 2.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Ambu A/S has been sold short.

Short Interest Ratio / Days to Cover

Ambu A/S has a short interest ratio ("days to cover") of 1.24, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ambu A/S has recently increased by 253.85%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Ambu A/S has a dividend yield of 0.33%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Ambu A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Ambu A/S is 10.00%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.01

News Sentiment

Ambu A/S has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Ambu A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ambu A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Ambu A/S has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/25/2026
• Today: 9/26/2026
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AMBBY
• Previous Symbol: OTCMKTS:AMBBY
• CIK: N/A
• Web: www.ambu.com
• Phone: (457) 225-2000
• Fax: N/A
• Employees: 5,384
• Year Founded: 1937

Profitability

• EPS (Trailing Twelve Months): $0.30
• Trailing P/E Ratio: 34.08
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $90.19 million
• Net Margins: 8.18%
• Pretax Margin: 10.71%
• Return on Equity: 8.49%
• Return on Assets: 6.75%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 2.77
• Quick Ratio: 1.73

Sales & Book Value

• Annual Sales: $894.37 million
• Price / Sales: 2.69
• Cash Flow: $0.62 per share
• Price / Cash Flow: 16.53
• Book Value: $3.80 per share
• Price / Book: 2.69

Miscellaneous

• Outstanding Shares: 234,970,000
• Free Float: N/A
• Market Cap: $2.40 billion
• Optionable: Not Optionable
• Beta: 0.93